MCID: NLD005
MIFTS: 27

Nail Disorder, Nonsyndromic Congenital, 10, malady

Categories: Genetic diseases, Skin diseases, Rare diseases

Aliases & Classifications for Nail Disorder, Nonsyndromic Congenital, 10,

About this section

Aliases & Descriptions for Nail Disorder, Nonsyndromic Congenital, 10,:

Name: Nail Disorder, Nonsyndromic Congenital, 10, 52 12
Nail Disorder, Non-Syndromic Congenital, 10 70 27
Nail Disorder, Nonsyndromic Congenital, 10 52 68
Onycholysis 39 68
Nonsyndromic Congenital Nail Disorder 10 11
 
Onychauxis Hyponychia and Onycholysis 70
Autosomal Recessive Nail Dysplasia 54
Claw-Shaped Nails 70
Ndnc10 70

Characteristics:

Orphanet epidemiological data:

54
autosomal recessive nail dysplasia:
Inheritance: Autosomal recessive; Prevalence: <1/1000000 (Worldwide)

HPO:

64
nail disorder, nonsyndromic congenital, 10,:
Inheritance: autosomal recessive inheritance

Classifications:

Orphanet: 54 
Rare skin diseases


External Ids:

OMIM52 614157
Disease Ontology11 DOID:0080088
Orphanet54 ORPHA280654
ICD10 via Orphanet31 Q84.6
MedGen37 C3279974
MeSH39 D054039
ICD1030 L60.1

Summaries for Nail Disorder, Nonsyndromic Congenital, 10,

About this section
UniProtKB/Swiss-Prot:70 Nail disorder, non-syndromic congenital, 10: A nail disorder characterized by a variable degree of onychauxis (thick nails), hyponychia, and onycholysis of all nails, with claw- shaped fingernails in some individuals. No other anomalies of ectodermal tissues, including hair, teeth, sweat glands, or skin, are noted, and individuals with dysplastic nails have normal hearing and normal psychomotor development.

MalaCards based summary: Nail Disorder, Nonsyndromic Congenital, 10,, also known as nail disorder, non-syndromic congenital, 10, is related to ectodermal dysplasia 3, witkop type and nail disorder, nonsyndromic congenital, 1, and has symptoms including onycholysis, koilonychia and beau's lines. An important gene associated with Nail Disorder, Nonsyndromic Congenital, 10, is FZD6 (Frizzled Class Receptor 6). Affiliated tissues include skin and prostate.

OMIM:52 Nonsyndromic congenital nail disorder-10 is characterized by onychauxis (thick nails), hyponychia, and onycholysis of... (614157) more...

Related Diseases for Nail Disorder, Nonsyndromic Congenital, 10,

About this section

Graphical network of diseases related to Nail Disorder, Nonsyndromic Congenital, 10,:



Diseases related to nail disorder, nonsyndromic congenital, 10,

Symptoms & Phenotypes for Nail Disorder, Nonsyndromic Congenital, 10,

About this section

Symptoms by clinical synopsis from OMIM:

614157

Clinical features from OMIM:

614157

Human phenotypes related to Nail Disorder, Nonsyndromic Congenital, 10,:

 64
id Description HPO Frequency HPO Source Accession
1 onycholysis64 HP:0001806

UMLS symptoms related to Nail Disorder, Nonsyndromic Congenital, 10,:


koilonychia, beau's lines, onychomadesis, thin nails, nail symptom/complaint, nail discomfort, nail bed hemorrhage, nail bed tenderness, abnormal nail growth

Drugs & Therapeutics for Nail Disorder, Nonsyndromic Congenital, 10,

About this section

Drugs for Nail Disorder, Nonsyndromic Congenital, 10, (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show all 26)
idNameStatusPhaseClinical TrialsCas NumberPubChem Id
1
Triamcinoloneapproved, vet_approvedPhase 4482124-94-731307
Synonyms:
(8S,9R,10S,11S,13S,14S,16R,17S)-9-fluoro-11,16,17-trihydroxy-17-(2-hydroxyacetyl)-10,13-dimethyl-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-3-one
11-beta,16-alpha,17-alpha,21-Tetrahydroxy-9-alpha-fluoro-1,4-pregnadiene-3,20-dione
11.Beta.,16.alpha.,17.alpha., 21-Tetrahydroxy-9.alpha.-fluoro-1,4-pregnadiene-3,20-dione
11.beta.,16.alpha.,17.alpha.,21-Tetrahydroxy-9.alpha.-fluoro-1,4-pregnadiene-3,20-dione
11β,16α,17α,21-tetrahydroxy-9α-fluoro-1,4-pregnadiene-3,20-dione
124-94-7
4-08-00-03629 (Beilstein Handbook Reference)
83474-03-7
9-Fluoro-11,16,17,21-tetrahydroxypregna-1,4-diene-3,20-dione
9-Fluoro-11beta,16alpha,17,21-tetrahydroxypregna-1,4-diene-3,20-dione
9-alpha-Fluoro-11-beta,16-alpha,17,21-tetrahydroxypregna-1,4-diene-3,20-dione
9-alpha-Fluoro-16-alpha-hydroxyprednisolone
9-fluoro-11β,16α,17,21-tetrahydroxypregna-1,4-diene-3,20-dione
9.Alpha.-Fluoro-11.beta.,16.alpha.,17,21-tetrahy
9.Alpha.-Fluoro-11.beta.,16.alpha.,17.alpha., 21-tetrahydroxypregna-1,4-diene-3,20-d
9.alpha.-Fluoro-11.beta.,16.alpha.,17,21-tetrahydroxy-1,4-pregnadiene-3,20-dione
9.alpha.-Fluoro-11.beta.,16.alpha.,17,21-tetrahydroxypregna-1,4-diene-3,20-dione
9.alpha.-Fluoro-11.beta.,16.alpha.,17.alpha.,21-tetrahydroxypregna-1,4-diene-3,20-dione
9.alpha.-Fluoro-16.alpha.-hydroxyprednisolone
9alpha-Fluoro-11beta,16alpha,17,21-tetrahydroxy-1,4-pregnadiene-3,20-dione
9alpha-Fluoro-11beta,16alpha,17,21-tetrahydroxypregna-1,4-diene-3,20-dione
9alpha-Fluoro-16alpha-hydroxyprednisolone
9α-fluoro-11β,16α,17,21-tetrahydroxypregna-1,4-diene-3,20-dione
9α-fluoro-11β,16α,17α,21-tetrahydroxypregna-1,4-diene-3,20-dione
9α-fluoro-16α-hydroxyprednisolone
AC-2072
AC1L1LDH
AC1Q5HJC
Adcortyl
Aristocort
Aristocort A
Aristocort Tablets
Aristogel
Aristospan
Azmacort
BPBio1_000154
BRD-K77554836-001-03-3
BRN 2341955
BSPBio_000140
Bio-0662
C21H27FO6
CHEMBL1451
CID31307
CL 19823
Celeste
Cinolone
Cinolone-T
D00385
D014221
DB00620
Delphicort
EINECS 204-718-7
EU-0101179
Fluoxiprednisolone
Fluoxyprednisolone
Flutex
Fougera
HMS1568G22
HMS2090D12
HSDB 3194
Kenacort
Kenacort (TN)
Kenacort-A
Kenacort-AG
Kenacort-Ag
Kenalog
Kenalog in Orabase
Kenalog-10
Kenalog-40
Kenalog-H
LS-698
Ledercort
Lopac0_001179
 
MLS000028542
MLS001066543
MLS002695935
MolPort-002-528-981
Mycolog
NCGC00021580-03
NCGC00021580-04
NCGC00021580-05
NCGC00021580-06
NCGC00021580-07
NCI60_000750
NSC 13397
NSC13397
Nasacort
Nasacort Aq
Nasacort Hfa
Omcilon
Omicilon
Oracort
Oralone
Orion
Polcortolon
Pregna-1,4-diene-3,20-dio
Pregna-1,4-diene-3,20-dione, 9-fluoro-11,16,17,21-tetrahydroxy-, (11beta,16alpha)
Pregna-1,4-diene-3,20-dione, 9-fluoro-11beta,16alpha,17,21-tetrahydroxy- (8CI)
Prestwick0_000120
Prestwick1_000120
Prestwick2_000120
Prestwick3_000120
Prestwick_438
Rodinolone
S1933_Selleck
SK-Triamcinolone
SMP1_000300
SMR000058333
SPBio_002079
Sk-Triamcinolone
T6376_SIGMA
TRIAMCINOLONE (SEE ALSO TRIAMCINOLONE ACETONIDE (76-25-5) AND TRIAMCINOLONE DIACETATE (67-78-7))
Tiamcinolonum
Tiamcinolonum [INN-Latin]
Tri-Nasal
Triacet
Triacort
Triam-Tablinen
Triamcet
Triamcinalone
Triamcinlon
Triamcinolon
Triamcinolona
Triamcinolona [INN-Spanish]
Triamcinolone (JP15/USP/INN)
Triamcinolone [USAN:INN:BAN:JAN]
Triamcinolone acetonide
Triamcinolone diacetate
Triamcinolone hexacetonide
Triamcinolonum
Triamcinolonum [INN]
Triatex
Tricortale
Triderm
Trilone
Tristoject
Trymex
UNII-1ZK20VI6TY
Vetalog
Volon
Volon A
WLN: L E5 B666 OV KU MUTJ A1 BF CQ E1 FV1Q FQ GQ
ZINC03882036
droxypregna-1,4-diene-3,20-dione
ione
nchembio.2007.53-comp7
triamcinolone
2
Apremilastapproved, investigationalPhase 464608141-41-911561674
Synonyms:
Apremilast
Apremilast (USAN)
Apremilastum
Aprémilast
CC-10004
 
CHEBI:558773
CHEMBL514800
CID11561674
D08860
N-[2-[1-(3-ethoxy-4-methoxy-phenyl)-2-methylsulfonyl-ethyl]-1,3-dioxo-isoindol-4-yl]acetamide
N-{2-[(1S)-1-(3-Ethoxy-4-methoxyphenyl)-2-(methylsulfonyl)ethyl]-1,3-dioxo-2,3-dihydro-1H-isoindol-4-yl}acetamide
3triamcinolone acetonidePhase 4482
4Triamcinolone diacetatePhase 4482
5Anti-Inflammatory AgentsPhase 410355
6Triamcinolone hexacetonidePhase 4482
7Immunosuppressive AgentsPhase 412770
8EMLAPhase 467
9
ClobetasolPhase 47625122-46-732798, 5311051
Synonyms:
(11beta,16beta)-21-chloro-9-fluoro-11,17-dihydroxy-16-methylpregna-1,4-diene-3,20-dione
(8S,9R,10S,11S,13S,14S,16S,17R)-17-(2-chloroacetyl)-9-fluoro-11,17-dihydroxy-10,13,16-trimethyl-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-3-one
(9R,17R)-17-(2-chloroacetyl)-9-fluoro-11,17-dihydroxy-10,13,16-trimethyl-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-3-one
17-(2-chloroacetyl)-9-fluoro-11,17-dihydroxy-10,13,16-trimethyl-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-3-one
21-Chloro-9-fluoro-11beta,17-dihydroxy-16beta-methylpregna-1,4-diene-3,20-dione
21-chloro-9-fluoro-11,17-dihydroxy-16-methylpregna-1,4-diene-3,20-dione
25122-41-2
AC-1775
AC1L1OG6
AC1NDRJ9
AC1NSJWK
BB_NC-1906
C22H28ClFO4
CHEBI:205919
CHEMBL1201362
CID10341542
CID32797
 
CID4630419
CID5311051
CID9844480
Clobecort Amex
Clobecort Amex (TN)
Clobetasol (INN)
Clobetasol [INN:BAN]
Clobetasolum
Clobetasolum [INN-Latin]
Clofenazon
D07715
EINECS 246-633-8
LS-174086
MolPort-005-909-335
NCGC00164580-01
STK801976
UNII-ADN79D536H
ZINC26892643
clobetasol
10glucocorticoidsPhase 44920
11Hormone AntagonistsPhase 412778
12Hormones, Hormone Substitutes, and Hormone AntagonistsPhase 412767
13HormonesPhase 413979
14Antirheumatic AgentsPhase 410627
15Peripheral Nervous System AgentsPhase 422776
16AnalgesicsPhase 411287
17Analgesics, Non-NarcoticPhase 46260
18Anti-Inflammatory Agents, Non-SteroidalPhase 44295
19
TavaboroleapprovedPhase 310174671-46-6
Synonyms:
 
5-Fluoro-1,3-dihydro-1-hydroxy-2,1-benzoxaborole
5-Fluoro-2,1-benzoxaborol-1(3H)-ol
20
Miconazoleapproved, investigational, vet_approvedPhase 3, Phase 1362422916-47-84189
Synonyms:
(+-)-1-(2,4-Dichloro-beta-((2,4-dichlorobenzyl)oxy)phenethyl)imidazole
1-(2,4-Dichloro-beta-((2,4-dichlorobenzyl)oxy)phenethyl)imidazole
1-(2,4-dichloro-beta-((2,4-dichlorobenzyl)oxy)phenethyl) imidazole
1-[2,4-Dichloro- beta-([2,4-dichloro- benzyl]oxy)phenethyl]imidazole
1-[2-(2,4-Dichloro-benzyloxy)-2-(2,4-dichloro-phenyl)-ethyl]-1H-imidazole
1-[2-(2,4-Dichlorophenyl)-2-[(2,4-dichlorophenyl)methoxy]ethyl]-1H-imidazole
1-[2-(2,4-dichlorobenzyloxy)-2-(2,4-dichlorophenyl)ethyl]-1H-imidazole
1-[2-(2,4-dichlorophenyl)-2-[(2,4-dichlorophenyl)methoxy]ethyl]imidazole
1-[2-(2,4-dichlorophenyl)-2-{[(2,4-dichlorophenyl)methyl]oxy}ethyl]-1H-imidazole
1-{2-[(2,4-dichlorobenzyl)oxy]-2-(2,4-dichlorophenyl)ethyl}-1H-imidazole
22832-87-7 (NITRATE)
22916-47-8
75319-47-0
AB00053500
AC1L1HM1
AKOS001574474
Aflorix(nitrate)
Albistat(nitrate)
Andergin(nitrate)
BPBio1_000279
BRD-A82396632-001-03-0
BRD-A82396632-008-02-7
BRN 0965511
BSPBio_000253
BSPBio_002033
CCRIS 7924
CHEBI:6923
CHEMBL91
CID4189
CPD-4501
Conofite(nitrate)
D00416
DB01110
Dactarin
Daktarin IV
Daktarin iv
DivK1c_000156
EINECS 245-324-5
Epi-Monistat(nitrate)
Femizol-M
Florid(nitrate)
Gyno-Daktar(nitrate)
HMS1568M15
HMS2090B21
I14-14342
IDI1_000156
Imidazole, 1-(2-(2,4-dichlorophenyl)-2-((2,4-dichlorophenyl)methoxy)ethyl)- (9CI)
KBio1_000156
KBio2_001445
KBio2_004013
KBio2_006581
KBio3_001533
KBioGR_000581
KBioSS_001445
LS-78378
Lotrimin AF(nitrate)
MCZ
MJR 1762
MLS002222203
Micantin (nitrate)
Miconasil Nitrate
 
Miconazol
Miconazol [INN-Spanish]
Miconazole
Miconazole (JP15/USP/INN)
Miconazole 3
Miconazole 3 Combination Pack
Miconazole 7 Combination Pack
Miconazole [USAN:BAN:INN:JAN]
Miconazole nitrate salt
Miconazole-7
Miconazolo
Miconazolo [DCIT]
Miconazolum
Miconazolum [INN-Latin]
Micozole
Minostate
MolPort-002-557-553
Monazole 7
Monista (nitrate)
Monistat
Monistat (TN)
Monistat 1 Combination Pack
Monistat 3 Dual-Pak
Monistat 3 Vaginal Ovules
Monistat 5 Tampon
Monistat 7 Dual-Pak
Monistat 7 Vaginal Suppositories
Monistat Dual- PAK
Monistat IV
Monistat iv (TN)
Monistat iv (tn)
Monistat-Derm
NCI60_001353
NCI60_001380
NINDS_000156
NSC 170986
NSC169434
NSC170986
Novo-Miconazole Vaginal Ovules
Oprea1_091955
Prestwick0_000067
Prestwick1_000067
Prestwick2_000067
Prestwick3_000067
Prestwick_335
R 18134
R-14,889
SMR001307249
SPBio_000976
SPBio_002174
STK834405
STOCK1S-93556
Spectrum2_001048
Spectrum3_000507
Spectrum4_000061
Spectrum5_001297
Spectrum_000965
UNII-7NNO0D7S5M
Vusion
Zimycan
imidazole, 1-(2-(2,4-dichlorophenyl)-2-((2,4-dichlorophenyl) methoxy)ethyl)- (9CI)
miconazole
21
Docetaxelapproved, investigational, Approved May 1996Phase 31918114977-28-5148124, 9877265
Synonyms:
(2aR,4S,4aS,6R,9S,11S,12S,12aR,12bS)-12b-(acetyloxy)-12-(benzoyloxy)-2a,3,4,4a,5,6,9,10,11,12,12a,12b-dodecahydro-4,6,11-trihydroxy-4a,8,13,13-tetramethyl-5-oxo-7,11-methano-1H-cyclodeca[3,4]benz[1,2-b]oxet-9-yl (aR,bS)-b-[[(1,1-dimethylethoxy)carbonyl]amino]-a-hydroxybenzenepropanoate
(2alpha,5beta,7beta,10beta,13alpha)-4-(acetyloxy)-13-({(2R,3S)-3-[(tert-butoxycarbonyl)amino]-2-hydroxy-3-phenylpropanoyl}oxy)-1,7,10-trihydroxy-9-oxo-5,20-epoxytax-11-en-2-yl benzoate
01885_FLUKA
114977-28-5
4-(Acetyloxy)-13alpha-({(2R,3S)-3-[(tert-butoxycarbonyl)amino]-2-hydroxy-3-phenylpropanoyl}oxy)-1,7beta,10beta-trihydroxy-9-oxo-5beta,20-epoxytax-11-en-2alpha-yl benzoate
4-(acetyloxy)-13alpha-({(2R,3S)-3-[(tert-butoxycarbonyl)amino]-2-hydroxy-3-phenylpropanoyl}oxy)-1,7beta,10beta-trihydroxy-9-oxo-5beta,20-epoxytax-11-en-2alpha-yl benzoate
AC-383
AC1L3WHJ
ANX-514
BIND-014
C11231
CHEBI:4672
CHEMBL92
CID148124
D07866
DB01248
Docetaxel
Docetaxel (INN)
Docetaxel anhydrous
Docetaxel, Trihydrate
EmDOC
 
HMS2089K08
InChI=1/C43H53NO14/c1-22-26(55-37(51)32(48)30(24-15-11-9-12-16-24)44-38(52)58-39(3,4)5)20-43(53)35(56-36(50)25-17-13-10-14-18-25)33-41(8,34(49)31(47)29(22)40(43,6)7)27(46)19-28-42(33,21-54-28)57-23(2)45/h9-18,26-28,30-33,35,46-48,53H,19-21H2,1-8H3,(H,44,5
MolPort-003-847-005
N-Debenzoyl-N-(tert-butoxycarbonyl)-10-deacetylpaclitaxel
N-Debenzoyl-N-(tert-butoxycarbonyl)-10-deacetyltaxol
N-debenzoyl-N-(tert-butoxycarbonyl)-10-deacetylpaclitaxel
N-debenzoyl-N-(tert-butoxycarbonyl)-10-deacetyltaxol
N-debenzoyl-N-Boc-10-deacetyl taxol
NSC-628503
PSMA-targeted docetaxel nanoparticle
RP-56976
SDP-014
TXL
Taxotere
Taxotere (TN)
Taxotere(R)
XRP-6976L
docetaxel
docetaxel 114977-28-5
nchembio.188-comp8
nchembio.2007.34-comp7
nchembio.573-comp11
nchembio853-comp8
22Pharmaceutical SolutionsPhase 37793
23Antifungal AgentsPhase 3, Phase 13615
24Anti-Infective AgentsPhase 3, Phase 121402
25Antimitotic AgentsPhase 35498
26
Terbinafineapproved, investigational, vet_approvedPhase 13391161-71-65402, 1549008
Synonyms:
(2E)-N,6,6-trimethyl-N-(1-naphthylmethyl)-2-hepten-4-yn-1-amine
(2E)-N,6,6-trimethyl-N-(naphthalen-1-ylmethyl)hept-2-en-4-yn-1-amine
(E)-N,6,6-trimethyl-N-(naphthalen-1-ylmethyl)hept-2-en-4-yn-1-amine
(E)-N-(6,6-Dimethyl-2-hepten-4-ynyl)-N-methyl-1-naphthalene methanamine
(E)-N-(6,6-Dimethyl-2-hepten-4-ynyl)-N-methyl-1-naphthalenemethylamine
(E)-N-(6,6-dimethyl-2-heptenynyl)-N-methyl-1-naphthalenementhamin hydrochloride
(e)-N-(6,6-Dimethyl-2-hepten-4-ynyl)-N-methyl-1-naphthalene methanamine
(e)-N-(6,6-Dimethyl-2-hepten-4-ynyl)-N-methyl-1-naphthalenemethylamine
91161-71-6
AC-12049
AC1LU7MZ
AKOS001451917
BIDD:GT0825
BRN 4256376
Bramazil
C08079
CHEBI:156831
CHEMBL822
CID1549008
D02375
DB00857
HMS2089B20
LS-94722
Lamasil
Lamasil (TN)
 
Lamisil
Lamisil AT
Lamisil Oral
Lamisil Tablet
Lamisil, Terbinex, Corbinal, Zabel, Terbinafine
MolPort-002-507-761
MolPort-004-637-919
NCGC00159346-02
NCGC00159346-03
S1725_Selleck
SF 86-327
SF-86-327
STK802069
STOCK5S-43972
TerbiFoam
Terbifoam
Terbina
Terbinafina
Terbinafine (USAN/INN)
Terbinafine HCl
Terbinafine [USAN:BAN:INN]
Terbinafine hydrochloride
Terbinafine, SF-86-327, Lamisil, TBNF
Terbinafinum
Ternbinafine HCl
UNII-G7RIW8S0XP
terbinafine

Interventional clinical trials:

idNameStatusNCT IDPhase
1Comparison of Efficacy of Intralesional Triamcinolone Injection and Clobetasol Propionate Ointment for Psoriatic NailsCompletedNCT01703325Phase 4
2An Investigator Initiated Open Label Study Evaluating the Efficacy and Tolerability of Oral Apremilast for the Treatment of Nail PsoriasisNot yet recruitingNCT03022617Phase 4
3Evaluation of the Cryotherapy in the Prevention of Nails Toxicity Induced by Taxotere® in Breast or Prostate CancerCompletedNCT00925418Phase 3
4Efficacy and Safety of AN2690 Topical Solution to Treat Onychomycosis of the ToenailCompletedNCT01302119Phase 3
5Efficacy and Safety Evaluation of AN2690 Topical Solution to Treat Onychomycosis of the ToenailCompletedNCT01270971Phase 3
6Safety and Pharmacokinetics of Terbinafine Hydrogen Chloride (HCl) Nail Lacquer in Patients With OnychomycosisCompletedNCT00691184Phase 1
7A Trial of Evonail® Solution for Prevention or Treatment of OnycholysisRecruitingNCT02670603
8Distal Erosions and Nail PsoriasisRecruitingNCT02813720
9Evaluation of Cryoprotection Induced Nail Toxicity Docetaxel Low Cumulative DoseRecruitingNCT02283983

Search NIH Clinical Center for Nail Disorder, Nonsyndromic Congenital, 10,


Cochrane evidence based reviews: onycholysis

Genetic Tests for Nail Disorder, Nonsyndromic Congenital, 10,

About this section

Genetic tests related to Nail Disorder, Nonsyndromic Congenital, 10,:

id Genetic test Affiliating Genes
1 Nail Disorder, Nonsyndromic Congenital, 1027

Anatomical Context for Nail Disorder, Nonsyndromic Congenital, 10,

About this section

MalaCards organs/tissues related to Nail Disorder, Nonsyndromic Congenital, 10,:

36
Skin, Prostate

Publications for Nail Disorder, Nonsyndromic Congenital, 10,

About this section

Variations for Nail Disorder, Nonsyndromic Congenital, 10,

About this section

UniProtKB/Swiss-Prot genetic disease variations for Nail Disorder, Nonsyndromic Congenital, 10,:

70
id Symbol AA change Variation ID SNP ID
1FZD6p.Arg511CysVAR_066398rs151339003

Clinvar genetic disease variations for Nail Disorder, Nonsyndromic Congenital, 10,:

5
id Gene Variation Type Significance SNP ID Assembly Location
1FZD6NM_003506.3(FZD6): c.1750G> T (p.Glu584Ter)SNVPathogenicrs151339002GRCh37Chr 8, 104342091: 104342091
2FZD6NM_003506.3(FZD6): c.1531C> T (p.Arg511Cys)SNVPathogenicrs151339003GRCh37Chr 8, 104340634: 104340634

Expression for genes affiliated with Nail Disorder, Nonsyndromic Congenital, 10,

About this section
Search GEO for disease gene expression data for Nail Disorder, Nonsyndromic Congenital, 10,.

Pathways for genes affiliated with Nail Disorder, Nonsyndromic Congenital, 10,

About this section

GO Terms for genes affiliated with Nail Disorder, Nonsyndromic Congenital, 10,

About this section

Sources for Nail Disorder, Nonsyndromic Congenital, 10,

About this section
2CDC
6CNVD
10DGIdb
15ExPASy
16FDA
17FMA
27GTR
28HGMD
29HMDB
30ICD10
31ICD10 via Orphanet
32ICD9CM
33IUPHAR
34KEGG
37MedGen
39MeSH
40MESH via Orphanet
41MGI
44NCI
45NCIt
46NDF-RT
49NINDS
50Novoseek
52OMIM
53OMIM via Orphanet
57PubMed
58QIAGEN
63SNOMED-CT via Orphanet
67Tumor Gene Family of Databases
68UMLS
69UMLS via Orphanet